BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8034616)

  • 1. Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells.
    Okabayashi Y; Kido Y; Okutani T; Sugimoto Y; Sakaguchi K; Kasuga M
    J Biol Chem; 1994 Jul; 269(28):18674-8. PubMed ID: 8034616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells.
    Okutani T; Okabayashi Y; Kido Y; Sugimoto Y; Sakaguchi K; Matuoka K; Takenawa T; Kasuga M
    J Biol Chem; 1994 Dec; 269(49):31310-4. PubMed ID: 7527043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.
    Rotin D; Margolis B; Mohammadi M; Daly RJ; Daum G; Li N; Fischer EH; Burgess WH; Ullrich A; Schlessinger J
    EMBO J; 1992 Feb; 11(2):559-67. PubMed ID: 1537335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements of the epidermal growth factor receptor for tyrosine phosphorylation of eps8 and eps15, substrates lacking Src SH2 homology domains.
    Alvarez CV; Shon KJ; Miloso M; Beguinot L
    J Biol Chem; 1995 Jul; 270(27):16271-6. PubMed ID: 7608194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
    Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
    Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors.
    Okada S; Yamauchi K; Pessin JE
    J Biol Chem; 1995 Sep; 270(35):20737-41. PubMed ID: 7544794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src.
    Sato K; Gotoh N; Otsuki T; Kakumoto M; Aoto M; Tokmakov AA; Shibuya M; Fukami Y
    Biochem Biophys Res Commun; 1997 Nov; 240(2):399-404. PubMed ID: 9388490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
    Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
    Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
    Gotoh N; Toyoda M; Shibuya M
    Mol Cell Biol; 1997 Apr; 17(4):1824-31. PubMed ID: 9121430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cadherin tyrosine residues that are phosphorylated and mediate Shc association.
    Xu Y; Carpenter G
    J Cell Biochem; 1999 Nov; 75(2):264-71. PubMed ID: 10502299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin stimulates association of insulin receptor substrate-1 with the protein abundant Src homology/growth factor receptor-bound protein 2.
    Tobe K; Matuoka K; Tamemoto H; Ueki K; Kaburagi Y; Asai S; Noguchi T; Matsuda M; Tanaka S; Hattori S
    J Biol Chem; 1993 May; 268(15):11167-71. PubMed ID: 8388384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
    Marengere LE; Pawson T
    J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.